Executive Overview
What changed, what is at risk, and what deserves attention now.
Comparison
Previous period (2026-08-18 to 2026-09-16)
Previous period (2026-08-18 to 2026-09-16)
Revenue forecast, next 30 days
iForecast revenue
MYR 0
MYR 0 to MYR 0
Priced from
0 units
at MYR 0.00 realised average selling price
Point estimate80% interval, calibrated on measured residualsModel v2.4.1
17 Oct 2026 to 15 Nov 2026, forecast from data current to 16 Oct 2026.
Inventory at risk
iStock-out risk valueMYR 0
No location is below its replenishment lead time in the current scope.
Excess stock valueMYR 0
Nothing above the 45-day excess threshold.
Stock in transitMYR 57,846
Recorded on the current snapshot and valued at cost. The snapshot holds a quantity with no arrival date, so it is not netted off days of cover and cannot be attributed to a delivery window. No purchase order feeds this figure.
Active alerts
i0Critical
0High
0Medium
1Low
Current campaign
iPayday 15% off Serum · Oct · in flight
Incremental revenueMYR 37,649
Incremental gross profit−MYR 22,392
Revenue uplift+16.9%
This campaign sells more at a worse margin. The next serum campaign should be a bundle or gift-with-purchase rather than a straight discount.
Campaign detail